Cellectis (CLLS) Cash from Operations (2015 - 2026)
Cellectis' (CLLS) quarterly Cash from Operations came in at 15410000.0 in Q1 2026, up 10.2% year-on-year from 13983902.7 in Q1 2025, and down 48.75% quarter-over-quarter from 10360000.0 in Q4 2025.
Cellectis (CLLS) Cash from Operations (2015 - 2026) Analysis & Trends
Cellectis' Cash from Operations history runs 12 years deep, the most recent figure standing at 15410000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 10.2% year-over-year to 15410000.0 in Q1 2026; TTM through Mar 2026 was 37651000.0, a 229.19% decrease from a year earlier, with the FY2025 full-year figure at 39401000.0, down 271.39% from the prior year.
- Cash from Operations declined to 15410000.0 in Q1 2026 per CLLS's latest filing, from 10360000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 52180000.0 in Q2 2024 and bottomed at 29761000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 15410000.0 (2026), against an average of 7377117.65.
- Across the five-year window, Cash from Operations soared 1501.82% in 2023 and tumbled 21942.55% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 2252000.0 in 2022, then surged by 1501.82% to 36073000.0 in 2023, then tumbled by 100.13% to 47000.0 in 2024, then tumbled by 21942.55% to 10360000.0 in 2025, then tumbled by 48.75% to 15410000.0 in 2026.
- Per Business Quant, the three latest CLLS Cash from Operations figures stand at 15410000.0 (Q1 2026), 10360000.0 (Q4 2025), and 1571000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -15.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.41 Mn |
| Mar 31, 2026 | -15.41 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Mar 31, 2025 | -17.16 Mn |
| Mar 31, 2025 | -17.16 Mn |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -5.83 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | 52.18 Mn |
| Jun 30, 2024 | 52.18 Mn |
| Mar 31, 2024 | -23.32 Mn |
| Mar 31, 2024 | -23.32 Mn |
| Dec 31, 2023 | 36.07 Mn |
| Dec 31, 2023 | 36.07 Mn |